Traves Brady
How to Read an FDA 483 Observation (And What It Means for Your Business)
The FDA Enforcement Pattern Nobody Is Talking About (And Why It Should Change How You Operate)
Supply Chain Audit: The 14 Questions Every Peptide Operator Should Ask Their Supplier
The Four Legal Lanes Peptide Businesses Actually Operate In
Most peptide operators don't know which lane they're in. That's not a knock — the regulatory landscape is genuinely complex, and most guidance is written for lawyers, not founders. This is a framework built for operators. Why "Which Lane?" Is the First Question